ASPM Inhibitors

Chemical Class Description: The class of ASPM inhibitors includes compounds that indirectly affect the function and activity of ASPM by targeting cellular mechanisms and pathways integral to cell division and neurodevelopment. These inhibitors, while not directly interacting with ASPM, modulate the cellular environment and processes in which ASPM operates. Compounds such as Paclitaxel, Vinblastine, Nocodazole, and Colchicine target microtubule dynamics, a critical aspect of ASPM's role in mitotic spindle orientation and cell division. CDK inhibitors like Roscovitine and Purvalanol A disrupt the cell cycle regulation, potentially impacting the phases where ASPM is active. Inhibitors such as BI 2536 and ZM447439, targeting PLK1 and Aurora kinases respectively, are involved in various aspects of mitotic processes, thereby potentially influencing ASPM's function in neurodevelopment.

Additionally, the antimetabolite 5-Fluorouracil affects DNA synthesis, which is crucial for cell division and thereby impacts ASPM activity. Monastrol and S-Trityl-L-cysteine, by inhibiting kinesin Eg5 and spindle assembly, respectively, disrupt the spindle dynamics crucial for ASPM's role. Wortmannin, as a PI3K inhibitor, represents a different approach, potentially altering signaling pathways that influence cell division and neurodevelopment where ASPM is active.